Pembrolizumab (KEYTRUDA®) trials for Advanced Solid Tumor

All Pembrolizumab (KEYTRUDA®) trials · All Advanced Solid Tumor trials

Phase breakdown

Recruiting trials studying Pembrolizumab (KEYTRUDA®) for Advanced Solid Tumor

• A Beta-only IL-2 ImmunoTherapY Study
  NCT05086692 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
  NCT04977453 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
  NCT05098132 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 47 locations

Common questions

How many trials study Pembrolizumab (KEYTRUDA®) for Advanced Solid Tumor?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.